Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD)
TELECONNECT
1 other identifier
interventional
60
1 country
1
Brief Summary
The TELECONNECT-SVD study is a prospective, randomized, multicenter trial aimed at testing the efficacy of a remotely delivered exercise protocol on brain functional connectivity in patients with small vessel disease (SVD)-related ischemic stroke. The study will recruit patients aged ≥60 with a history of lacunar stroke, minimal disability (modified Rankin Scale score 0-1), and low physical activity levels. The trial will include 60 participants randomized 1:1 to either a 24-week telecoached exercise intervention or usual care. The exercise program consists of multicomponent physical exercises delivered remotely twice a week. Assessments will be conducted at baseline, 12 weeks, 24 weeks, and 48 weeks. Primary outcomes include changes in brain functional connectivity assessed by high-density EEG and improvements in physical fitness measured by the Senior Fitness Test. Secondary outcomes encompass changes in physical activity levels, anthropometric measurements, and vital signs. The study employs a "wait list" design, where the control group receives the intervention after the initial 24-week period. This approach allows for assessment of the intervention's immediate effects and the retention of benefits after cessation. Key features of the protocol include:
- Use of telecoaching to enhance adherence to the exercise program
- Comprehensive assessment of brain connectivity using advanced EEG analysis techniques
- Focus on patients with SVD, who may benefit significantly from exercise interventions
- Evaluation of both neurophysiological and clinical outcomes The study aims to provide evidence for the potential benefits of exercise in enhancing brain connectivity and physical fitness in SVD patients, potentially informing future treatment guidelines and preventive strategies for this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2024
CompletedFirst Posted
Study publicly available on registry
July 29, 2024
CompletedStudy Start
First participant enrolled
May 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 2, 2025
November 1, 2025
1.7 years
July 23, 2024
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Senior Fitness Test score
Change in the Senior Fitness score from before to after the 24-week physical exercise intervention
24 weeks
Secondary Outcomes (4)
Change in International Physical Activity Questionnaire (IPAQ) score
24 weeks
Change in Body Mass Index
24 weeks
Change in blood pressure
24 weeks
Change in heart rate
24 weeks
Other Outcomes (1)
Change in brain functional connectivity
24 weeks
Study Arms (2)
Immediate intervention
EXPERIMENTALParticipants will be allocated to physical activity intervention during the 24 weeks of follow-up.
Delayed intervention
OTHERParticipants will not be randomized to physical activity intervention during the first 24 weeks of follow-up. They will be randomized after the 24 weeks of follow-up.
Interventions
Randomization to a 24-week physical exercise program
Eligibility Criteria
You may qualify if:
- Age ≥60 years;
- History of lacunar stroke occurred between 3 months and 10 years from screening and confirmed by neuroimaging or clinical data by an expert stroke physician;
- Modified Rankin Scale (mRS) score of 0-1, indicating no symptoms or no significant disability;
- A level of physical activity below recommended targets, i.e. \<150 minutes per week of moderate-to-vigorous exercise (24);
- Ability to sign informed consent.
You may not qualify if:
- Uncontrolled hypertension;
- Heart disease impairing the possibility of safely following an exercise protocol at the discretion of the treating physician;
- Primary or secondary epilepsy;
- Prostheses, implants, and any device that might impair the performance of either high-density electroencephalogram or the exercise intervention;
- Cognitive impairment (Mini Mental State Examination score ≤26 at follow-up);
- Lack of access to Internet-based facilities or poor technological alphabetization impairing the adherence to the trial protocol;
- Any major physical or psychiatric comorbidity that in the judgement of the treating physician might compromise the ability to undergo an exercise intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UOC Neurologia e Stroke Unit
Avezzano, L'Aquila, 67051, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes will be assessed by investigators blinded to participants' allocation.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Neurology
Study Record Dates
First Submitted
July 23, 2024
First Posted
July 29, 2024
Study Start
May 2, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 2, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
IPD will be available from the central contact person upon reasonable request.